Skip to main content
. 2021 Sep 30;11:753677. doi: 10.3389/fonc.2021.753677

Figure 2.

Figure 2

Schematic diagram of TIM-3 identification, TIM-3 inhibitor development, and TIM-3 blockade in cancer and leukemia therapies in clinical trials.